chr22-19941727-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006440.5(TXNRD2):c.77T>G(p.Val26Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000444 in 1,487,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006440.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNRD2 | NM_006440.5 | c.77T>G | p.Val26Gly | missense_variant | 1/18 | ENST00000400521.7 | NP_006431.2 | |
COMT | NM_000754.4 | c.-262A>C | upstream_gene_variant | ENST00000361682.11 | NP_000745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNRD2 | ENST00000400521.7 | c.77T>G | p.Val26Gly | missense_variant | 1/18 | 1 | NM_006440.5 | ENSP00000383365.1 | ||
COMT | ENST00000361682.11 | c.-262A>C | upstream_gene_variant | 1 | NM_000754.4 | ENSP00000354511.6 |
Frequencies
GnomAD3 genomes AF: 0.000290 AC: 44AN: 151770Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000109 AC: 1AN: 91588Hom.: 0 AF XY: 0.0000193 AC XY: 1AN XY: 51724
GnomAD4 exome AF: 0.0000165 AC: 22AN: 1335476Hom.: 0 Cov.: 31 AF XY: 0.0000167 AC XY: 11AN XY: 658686
GnomAD4 genome AF: 0.000290 AC: 44AN: 151876Hom.: 0 Cov.: 33 AF XY: 0.000189 AC XY: 14AN XY: 74252
ClinVar
Submissions by phenotype
Glucocorticoid deficiency 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 11, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2024 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function - |
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 25, 2023 | ClinVar contains an entry for this variant (Variation ID: 407094). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TXNRD2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.06%). This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 26 of the TXNRD2 protein (p.Val26Gly). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.77T>G (p.V26G) alteration is located in exon 1 (coding exon 1) of the TXNRD2 gene. This alteration results from a T to G substitution at nucleotide position 77, causing the valine (V) at amino acid position 26 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at